A New Kind of
Medical Device Company.

At Nuvectra™, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers.

A New Kind of
Medical Device Company.

At Nuvectra™, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers.

We Don’t Stop There.

At Nuvectra, we know medical technology is complicated and can be difficult to use. Our commitment also includes developing products with intuitive designs and simplified features that make using our systems easier for clinicians and patients.

Although Nuvectra is new to the market, we were built from the more than 40 years of experience of Greatbatch, Inc., a leading supplier of critical technologies to the largest medical device companies in the world. Nuvectra’s leadership and product development (R&D) teams consist of experienced and recognized leaders in the medical device industry, including key opinion-leading physicians. Our promise is to listen to and work closely with healthcare professionals and patients to improve the outcomes and usability of medical devices.

Nuvectra: A Publicly Traded Company.

On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis. Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol “NVTR.”

Contact Us

For questions and inquiries regarding Nuvectra or the Algovita SCS System, please contact us:

Nuvectra
5830 Granite Parkway
11th Floor
Plano, TX 75024
1-844-727-7897